• ATRA Restores Niraparib Sensitivity After Cisplatin

  2026-08-23

  The reference study shows that all-trans retinoic acid can reduce cisplatin-induced resistance to PARP inhibition in epithelial ovarian cancer models. Its central contribution is a sequential treatment strategy in which cisplatin is followed by Niraparib maintenance with ATRA, supported by molecular evidence implicating NAD+ metabolism, ALDH1A1, PARP1, NAMPT, and CHK1.

• Catalpol in Osteoporosis Research: Workflow & Tips

  2026-08-22

  Catalpol provides a mechanism-led workflow for connecting bone microstructure, osteoclast apoptosis, and the Sirt6-ERα-FasL axis in estrogen-deficiency models. This guide translates the key ovariectomized-rat findings into practical dosing, cell-based assays, controls, and troubleshooting steps, while placing Catalpinoside in broader preclinical research context.

• LC-MS/MS Metabolomics of Carbapenemase Producers

  2026-08-22

  Dixon and colleagues used LC-MS/MS metabolomics to distinguish carbapenemase-producing Enterobacterales from non-producing isolates under antibiotic-free growth conditions. Their biomarker and machine-learning framework links resistance with altered central metabolism, transport, nucleotide pathways, and biofilm-associated biology while indicating a possible route to faster CPE detection.

• Nuclear cGAS, CHK2, and L1 Genome Defense

  2026-08-21

  The reference study identifies a nuclear cGAS–CHK2–TRIM41 pathway that suppresses LINE-1 retrotransposition by promoting ubiquitination and degradation of ORF2p. Its findings connect DNA damage signaling with post-translational control of mobile genetic elements, providing a mechanistic framework for genome-stability research in aging and cancer.

• Luminescent ATP Detection Assay Kit for Colitis

  2026-08-20

  The Luminescent ATP Detection Assay Kit provides a sensitive firefly luciferase ATP assay for connecting cellular energy state with NOX2/ROS/mitochondrial inflammation research. This guide explains how to use ATP as an orthogonal readout in ulcerative colitis models without confusing total ATP with direct proof of mitochondrial or inflammasome activity.

• Nadolol (SQ-11725) Workflow Guide

  2026-08-20

  Nadolol (SQ-11725) combines non-selective beta-adrenergic receptor antagonism with transporter-relevant pharmacokinetics, making it useful for linking receptor biology to exposure and distribution. This workflow guide shows how to build reproducible assays for hypertension research, angina pectoris studies, and vascular headache research while applying disease-state PK lessons from recent transporter research.

• Ertapenem: A Translational Lens on Resistance

  2026-08-19

  Ertapenem sodium salt offers more than a susceptibility endpoint: it can help connect antibacterial activity with carbapenemase genotype, plasmid localization, and transmission risk. This research-focused guide interprets ertapenem data within the Guangdong CREC study while clarifying assay design, pharmacokinetics, and limitations.

• Carbapenemase Transmission in Enterobacter cloacae

  2026-08-19

  Chen et al. characterized carbapenemase-encoding genes, plasmid transfer, mobile genetic elements, and clonal relationships in carbapenem-resistant Enterobacter cloacae collected from eight Guangdong teaching hospitals. The study shows that blaNDM-1 was widespread and highly transferable, providing a practical framework for linking resistance determinants with hospital transmission risk.

• Cefoperazone Sodium Salt Assay Workflow Guide

  2026-08-18

  Build more reproducible antibacterial assays with Cefoperazone sodium salt, from dissolution and broth dilution through MIC/MBC confirmation and resistance profiling. The workflow also shows how to connect in vitro findings with carefully bounded biliary tract infection research without overextending the evidence.

• Streptavidin-HyperFluor 647 Workflow Guide

  2026-08-18

  Streptavidin-HyperFluor 647 converts biotinylated antibodies, nucleic acids, and proximity-labeling products into bright red fluorescence for microscopy and flow analysis. This guide explains how to pair the conjugate with click-compatible BmTyr workflows while avoiding the critical mistake of treating a biotin-free labeling platform as a direct streptavidin assay.

• Aztreonam: Monocyclic β-Lactam Research Guide

  2026-08-17

  Aztreonam is a monocyclic β-lactam antibiotic with selective activity against Gram-negative aerobic bacteria through inhibition of bacterial cell wall synthesis. Product data also support research into bone marrow progenitor cell inhibition, hepatic cytochrome P450 effects, solubility, and controlled compound handling.

• BML-277: Practical Chk2 Inhibitor Workflows

  2026-08-17

  BML-277 combines nanomolar biochemical potency with a cell-compatible concentration range for dissecting checkpoint signaling, T-cell radioprotection, and DNA damage responses. This guide connects reproducible kinase and apoptosis assays with a cautious, hypothesis-driven extension into the CHK2–cGAS–TRIM41 pathway.

• S Tag Peptide A6007: Practical Fusion-Tag Workflow

  2026-08-16

  S Tag Peptide A6007 provides a 15-amino-acid sequence for genetically encoded N- or C-terminal fusion, supporting recombinant protein detection, antibody-based capture, and protein solubility improvement. It should be evaluated as part of a validated fusion construct rather than used as a standalone RNase reagent or assumed to improve every target protein.

• Imipenem: Mechanism-Led Assay Design

  2026-08-15

  Imipenem is a semisynthetic thienamycin antibiotic with a distinctive PBP-centered mechanism. This guide translates its molecular activity into better antibacterial research assays, immune response modulation studies, and sepsis animal model interpretation.

• Nigericin for pH and Mitochondrial Assays

  2026-08-14

  Nigericin converts potassium–proton exchange into measurable changes in intracellular pH, mitochondrial behavior, and cell fate. This practical guide covers stock preparation, dose-finding, cancer-cell workflows, GSDMD-linked readouts, and carefully bounded extensions to metabolic antibiotic research.

7921 records 1/529 page Next 12345 下5页 Last page